New Reagent Aids in Diagnosis of Connective Tissue Disease in Hard-to-Diagnose Autoimmune Diseases, Reducing Time to Diagnosis and Improving Patient Outcomes ...
Nearly 50% of American adults living with diabetes will be affected by diabetic neuropathy complications in their lifetime...
Roche announced new data from the Phase II FENopta study showing that investigational, oral fenebrutinib is brain penetrant and reduces brain lesions in people with relapsing multiple sclerosis (RMS) with a consistent safety profile to other fenebrutinib trials. The late-breaking data were featured in an oral presentation at the 9th Joint ECTRIMS-ACTRIMS Meeting (European and Americas Committees for Treatment and Research in Multiple Sclerosis)....
Neoss Group, a leading innovator in dental implant solutions, is proud to announce that it has received EU Medical Device Regulation (MDR) certification by its Notified Body, the BSI Group, the Netherlands B.V. for its implants and abutments. ...
SigTuple’s AI100 with ShonitTM receives U.S. FDA 510(k) Clearance...
Company Continues to Build Momentum with Most Recent Portfolio Expansion....
Patients implanted with the Evoke® System now eligible for full-body MRI scans...
A monumental step towards getting healthcare AI to augment critical care and emergency care...
Genesis MedTech, a leading medical device company, announced that its absorbable sutures with antibacterial protection have successfully obtained approval from the China's National Medical Products Administration (NMPA) for market release....
Marking a significant advancement in respiratory care...
